MCW Human Induced Pluripotent Stem Cell (iPSC) Program
To advance translational and precision medicine research, the CVRC has established the Human Induced Pluripotent Stem Cell (iPSC) Program funded by the Advancing a Healthier Wisconsin Endowment (2019-2022) and the MCW Dean’s Program Development funds (2023-Present). Over 600 square feet within the center provides quality iPSCs from a matching biorepository, consisting of somatic cells obtained from patient’s representative of the region/community in which we serve. The core is brought to you by a collaboration between the Cardiovascular Research Center, Department of Physiology and the Department of Pediatrics, Cardiology.
The Core Offers:
- Human iPSC reprogramming from peripheral blood monocytes or fibroblasts (skin biopsy)
- Human iPSC cell line differentiation services into endothelial cells, cardiomyocytes, or vascular smooth muscle cells
- iPSC CRISPR gene knockout/knock-in or single nucleotide editing
- Premade cell products from bank or select validated external sources
- Methodological development (e.g., organoids, additional cell types)
- Training for laboratory staff and pre/postdoctoral trainees on these methodologies
- And more!
iPSC Staff


